Onivyde (Ipsen Biopharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Onivyde drug offered from Ipsen Biopharmaceuticals, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ipsen Biopharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | IRINOTECAN HYDROCHLORIDE |
| SUBSTANCE NAME: | IRINOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-10-22 |
| END MARKETING DATE: | 0000-00-00 |
Onivyde HUMAN PRESCRIPTION DRUG Details:
| Item Description | Onivyde from Ipsen Biopharmaceuticals, Inc. |
| LABELER NAME: | Ipsen Biopharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4.3(mg/mL) |
| START MARKETING DATE: | 2015-10-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 15054-0043_8d896725-9fc1-48b4-92af-17827bdc663d |
| PRODUCT NDC: | 15054-0043 |
| APPLICATION NUMBER: | NDA207793 |
Other IRINOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
